显性消化道出血中早期胶囊内镜与器械辅助小肠镜的诊断与治疗价值:系统评价与荟萃分析
该系统评价与荟萃分析比较了显性消化道出血中早期与非早期小肠胶囊内镜和器械辅助小肠镜的诊断与治疗价值,共纳入39项研究4825例患者。早期组活动性出血、阳性诊断和治疗干预的比值比均显著更高,再出血率更低。
要点
- 早期小肠胶囊内镜和器械辅助小肠镜的诊断与治疗价值均优于非早期。
- 早期组活动性出血OR为5.09,阳性诊断OR为3.99,治疗干预OR为3.86。
- 早期小肠胶囊内镜和器械辅助小肠镜再出血率更低,OR为0.40。
核心结论
- 早期小肠检查在显性消化道出血评估中的作用明确,影响诊断、治疗干预和预后。
- 仍需比较性研究来确定最佳时机。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、ScienceDirect和Cochrane对照试验中心注册库,纳入比较早期与非早期小肠胶囊内镜和器械辅助小肠镜的研究。
- 共纳入39项研究,4825例患者;早期的时间间隔不一,小肠胶囊内镜在14天内,器械辅助小肠镜在72小时内。
- 采用随机效应荟萃分析,并评估报告质量。
主要发现
- 早期器械辅助小肠镜的汇总诊断率和治疗率分别为7.97%和20.89%,均优于小肠胶囊内镜(P < .05)。
- 早期组活动性出血的OR为5.09(I²=53%),阳性诊断的OR为3.99(I²=45%),治疗干预的OR为3.86(I²=67%)(P < .01)。
- 诊断率的亚组效应仅在早期组样本量方面被发现。
- 按早期器械辅助小肠镜时间间隔分类的研究间未发现差异(I² < 5%),但分析因数据缺乏而受限。
- 早期小肠胶囊内镜和器械辅助小肠镜再出血更低(OR为0.40;P < .01;I²=0%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 亚组分析仅在早期组样本量方面发现诊断率效应。
- 按早期器械辅助小肠镜时间间隔分类的研究间未发现差异(I² < 5%),但分析因数据缺乏而受限。
- 仍需比较性研究来确定最佳时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Small-bowel capsule endoscopy (SBCE) and device-assisted enteroscopy (DAE) are essential in obscure GI bleeding (OGIB) management. However, the best timing for such procedures remains unknown. This meta-analysis aimed to compare, for the first time, diagnostic and therapeutic yields, detection of active bleeding and vascular lesions, recurrent bleeding, and mortality of "early" versus "nonearly" SBCE and DAE. METHODS: MEDLINE, ScienceDirect, and Cochrane Central Register of Controlled Trials were searched to identify studies comparing early versus nonearly SBCE and DAE. Random-effects meta-analysis was performed; reporting quality was assessed. RESULTS: From 1974 records, 39 were included (4825 patients). Time intervals for the early approach varied, within 14 days in SBCE and 72 hours in DAE. The pooled diagnostic and therapeutic yields of early DAE were superior to those of SBCE (7.97% and 20.89%, respectively; P < .05). The odds for active bleeding (odds ratio [OR], 5.09; I2 = 53%), positive diagnosis (OR, 3.99; I2 = 45%), and therapeutic intervention (OR, 3.86; I2 = 67%) were higher in the early group for SBCE and DAE (P < .01). Subgroup effects in diagnostic yield were only identified for the early group sample size. Our study failed to identify differences when studies were classified according to time intervals for early DAE (I2 < 5%), but the analysis was limited because of a lack of data availability. Lower recurrent bleeding in early SBCE and DAE was observed (OR, .40; P < .01; I2 = 0%). CONCLUSIONS: The role of small-bowel studies in the early evaluation of OGIB is unquestionable, impacting diagnosis, therapeutic intervention, and prognosis. Comparative studies are still needed to identify optimal timing.
引用
- Estevinho MM, Pinho R, Fernandes C, et al. Diagnostic and therapeutic yields of early capsule endoscopy and device-assisted enteroscopy in the setting of overt GI bleeding: a systematic review with meta-analysis. Gastrointest Endosc. 2021. PMID: 34952093. doi:10.1016/j.gie.2021.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。